These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2983003)

  • 1. Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions.
    Brioen P; Thomas AA; Boeyé A
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():609-13. PubMed ID: 2983003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between poliovirus neutralization and aggregation.
    Thomas AA; Vrijsen R; Boeyé A
    J Virol; 1986 Aug; 59(2):479-85. PubMed ID: 3016307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
    Emini EA; Ostapchuk P; Wimmer E
    J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.
    Emini EA; Kao SY; Lewis AJ; Crainic R; Wimmer E
    J Virol; 1983 May; 46(2):466-74. PubMed ID: 6188863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of poliovirus by antibody-mediated polymerization.
    Brioen P; Dekegel D; Boeyé A
    Virology; 1983 Jun; 127(2):463-8. PubMed ID: 6306919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
    Thomas AA; Brioen P; Boeyé A
    J Virol; 1985 Apr; 54(1):7-13. PubMed ID: 2983121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsid destabilization is required for antibody-mediated disruption of poliovirus.
    Delaet I; Boeyé A
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():581-7. PubMed ID: 8126454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neutralization of animal viruses.
    Dimmock NJ
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1015-22. PubMed ID: 6202836
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.